C.M. Bidwell & Associates’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15
Closed -$2.76K 572
2023
Q2
$2.76K Hold
15
﹤0.01% 433
2023
Q1
$2.39K Hold
15
﹤0.01% 442
2022
Q4
$2.04K Hold
15
﹤0.01% 451
2022
Q3
$2K Sell
15
-5
-25% -$681 ﹤0.01% 426
2022
Q2
$2K Hold
20
﹤0.01% 441
2022
Q1
$3K Sell
20
-537
-96% -$76.2K ﹤0.01% 452
2021
Q4
$98K Buy
557
+16
+3% +$2.67K 0.06% 242
2021
Q3
$84K Buy
+541
New +$78.7K 0.06% 247

Other funds holding NOVT

C.M. Bidwell & Associates's NOVT Position: Q3 2023 in Review

C.M. Bidwell & Associates sold out of Novanta (NOVT) in Q3 2023, closing a stake of 15 shares — an estimated $2.76K sold.

C.M. Bidwell & Associates first reported a position in NOVT in Q3 2021 and held it in 8 quarters. The position peaked at $98K in Q4 2021. 263 funds tracked by Wall St. Rank hold NOVT as of Q3 2023.

  • C.M. Bidwell & Associates reported no remaining Novanta position as of Q3 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 15 Novanta shares in Q3 2023, an estimated $2.76K.
  • C.M. Bidwell & Associates first reported a position in Novanta in Q3 2021 and held it in 8 quarters.
  • C.M. Bidwell & Associates's Novanta position peaked at $98K in Q4 2021.
  • 263 funds tracked by Wall St. Rank held Novanta as of Q3 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.